News | September 26, 2023
Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
The company will develop and produce premixes for human nutrition applications
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
Subscribe To Our Newsletter & Stay Updated
